PT1068208E - Derivados do azatriciclo¬3.3.1.1|decano e composicoes farmaceuticas contendo os mesmos - Google Patents

Derivados do azatriciclo¬3.3.1.1|decano e composicoes farmaceuticas contendo os mesmos

Info

Publication number
PT1068208E
PT1068208E PT99909806T PT99909806T PT1068208E PT 1068208 E PT1068208 E PT 1068208E PT 99909806 T PT99909806 T PT 99909806T PT 99909806 T PT99909806 T PT 99909806T PT 1068208 E PT1068208 E PT 1068208E
Authority
PT
Portugal
Prior art keywords
hydrogen
substituent
azatriciclo
dean
derivatives
Prior art date
Application number
PT99909806T
Other languages
English (en)
Portuguese (pt)
Inventor
Merouane Bencherif
Patrick Michael Lippiello
Peter Anthony Crooks
Haeil Park
Balwinder Singh Bhatti
William Scott Caldwell
Gary Maurice Dull
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/054,175 external-priority patent/US5952339A/en
Priority claimed from US09/053,937 external-priority patent/US6057446A/en
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of PT1068208E publication Critical patent/PT1068208E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT99909806T 1998-04-02 1999-03-03 Derivados do azatriciclo¬3.3.1.1|decano e composicoes farmaceuticas contendo os mesmos PT1068208E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,175 US5952339A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US09/053,937 US6057446A (en) 1998-04-02 1998-04-02 Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds

Publications (1)

Publication Number Publication Date
PT1068208E true PT1068208E (pt) 2003-09-30

Family

ID=26732410

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99909806T PT1068208E (pt) 1998-04-02 1999-03-03 Derivados do azatriciclo¬3.3.1.1|decano e composicoes farmaceuticas contendo os mesmos

Country Status (13)

Country Link
EP (1) EP1068208B1 (enExample)
JP (1) JP2002510690A (enExample)
KR (1) KR100591805B1 (enExample)
AT (1) ATE240331T1 (enExample)
AU (1) AU2892999A (enExample)
BR (1) BR9907172A (enExample)
CA (1) CA2317567A1 (enExample)
DE (1) DE69907894T2 (enExample)
DK (1) DK1068208T3 (enExample)
ES (1) ES2199561T3 (enExample)
MX (1) MXPA00009634A (enExample)
PT (1) PT1068208E (enExample)
WO (1) WO1999051602A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
MY145722A (en) * 2000-04-27 2012-03-30 Abbott Lab Diazabicyclic central nervous system active agents
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
WO2001082978A2 (en) * 2000-05-01 2001-11-08 Targacept, Inc. Imaging of nicotinic acetylcholine receptor subtypes
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
EP2497771A1 (en) * 2007-03-23 2012-09-12 Abbott Laboratories 4 -substituted azaadamantane derivatives and methods of use thereof
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
EP2619205B1 (en) 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrate of an azaadamantane derivative
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
JP3510937B2 (ja) * 1995-06-05 2004-03-29 ポリプラスチックス株式会社 耐熱性ポリエステルアミドスルフィド樹脂及びその組成物
US6022868A (en) * 1995-06-29 2000-02-08 Novo Nordisk Als Substituted azacyclic or azabicyclic compounds
EP0853621A1 (en) * 1995-09-22 1998-07-22 Novo Nordisk A/S Novel substituted azacyclic or azabicyclic compounds

Also Published As

Publication number Publication date
KR100591805B1 (ko) 2006-06-26
DE69907894D1 (de) 2003-06-18
ES2199561T3 (es) 2004-02-16
EP1068208B1 (en) 2003-05-14
EP1068208A1 (en) 2001-01-17
DK1068208T3 (da) 2003-09-01
CA2317567A1 (en) 1999-10-14
KR20010052173A (ko) 2001-06-25
AU2892999A (en) 1999-10-25
JP2002510690A (ja) 2002-04-09
WO1999051602A1 (en) 1999-10-14
BR9907172A (pt) 2000-10-10
DE69907894T2 (de) 2004-03-11
MXPA00009634A (es) 2005-06-20
ATE240331T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
WO2003082798A8 (es) Compuestos naturales y derivados de éstos para la prevención y el tratamiento de enfermedades cardiovasculares, hepáticas, renales y para aplicaciones cosméticas
FR2727682B1 (enExample)
IL129768A0 (en) Antithrombotic organic nitrates
CA2400804A1 (en) Stable emulsion compositions of cycloalkene derivatives
WO1999033858A3 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
IL114726A0 (en) Noribogaine derivatives and pharmaceutical compositions containing the same
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
BR9907172A (pt) Derivados de azatriciclo[3.3.1.1] decano e composições farmacêuticas contendo-os
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
WO1999009965A3 (en) Anti-inflammatory agent
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
PT1447400E (pt) Composto bicíclico
KR890014443A (ko) 신규한 치환 나프타렌 화합물 및 동 화합물을 함유하는 액정조성물
ATE338576T1 (de) Kosmetische zusammensetzungen
DK1066287T3 (da) Azatricykliske forbindelser
WO2001051004A3 (en) Anti-cancer agent containing naphthoquinone compound
EP0335979A4 (en) Thienopyrimidine derivatives
MXPA04001171A (es) Compuestos policiclicos condensados.
CA2191947A1 (en) Pirydyl Imidazole Derivatives and Processes for the Preparation Thereof
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
EP0790247A4 (en) TETRAHYDROISOCHINOLINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM